In the development of antimicrobial agents, we designed and synthesized novel tetrazole derivatives. The structures of compounds 6a-f and 7a-f were characterized by IR, 1 H NMR,
Introduction
Microbial infections become an increasingly serious and challenging problem for human health across the world. Such infections most commonly affect patients with decreased immunity, neoplastic disorders and undergoing organ transplantation [1] . This situation stimulates an urgent need to develop novel antimicrobial agents from newer classes of compounds. Fluorinated compounds have proved invaluable as antimicrobial agents, and have been used for the treatment of obesity and various diseases associated with the cardiovascular and central nervous systems [2] . The incorporation of fluorine into a potential drug molecule can improve the therapeutic efficacy due to hydrogen bonding interactions at the active sites of enzyme [3] .
The naturally occurring flavones display biological activity ( Figure 1 ) [4] [5] [6] [7] [8] [9] [10] . One of the recognized functions of flavonoids in plants is their protective role against microbial incursion [4] . These compounds play an important role in drug discovery processes.
The synthetic versatility of tetrazole is due to its widespread applications in medicinal chemistry. Tetrazole scaffold is part of highly effective drugs such as candesartan, pamiroplast and pranlukast ( Figure 1 ) [11] . Tetrazole can be considered a carboxylic acid analogue because of similar pK a values and planar delocalized systems. Tetrazole derivatives are resistant to various biological degradation processes, which contributes to bioavailability [12, 13] . These factors play a role in applications of tetrazole derivatives as anticancer [14] , antifungal [15] , antitubercular [16] , anti-HIV [17] , antioxidant [18] and hormonal agents [19] .
It can be suggested that the presence of fluorine, flavone and tetrazole in a single molecular framework ( Figure 2 ) would increase biological activity of the compound. In continuation of our earlier work on the synthesis of tetrazole derivatives [20] , we now report the synthesis of such compounds and evaluation of their antimicrobial and anti-biofilm activities.
Results and discussion

Chemistry
Substituted 3-hydroxychromones 5a-f were synthesized as described in our previous report [21] (Scheme 1). ClaisenSchmidt condensation of substituted 2-hydroxyacetophenones 3a-f with 4-fluorobenzaldehyde in ethanolic solution of potassium hydroxide at room temperature furnished substituted chalcones 4a-f which were converted into corresponding substituted 3-hydroxychromones 5a-f upon oxidative cyclization using hydrogen peroxide in ethanol.
3-[(1H-tetrazol-5-yl)methoxy]-2-(4-fluorophenyl)-4H-chromen-4-ones 7a-f were synthesized from the corresponding 3-hydroxychromones 5a-f (Scheme 2). First, compounds 5a-f were alkylated with 2-chloroacetonitrile in the presence of K 2 CO 3 in N,N′-dimethylformamide (DMF) at room temperature for 3-4 h to afford the substituted 2-(2-(4-fluorophenyl)-4-oxo-4H-chromen-3-yloxy) acetonitriles 6a-f in 71%-86% yield. Then, treatment of 6a-f with sodium azide and zinc bromide in water at 100°C for 4-5 h furnished the final products 7a-f in 73%-81% yield. All compounds were characterized by spectroscopic techniques of 1 H NMR, 13 C NMR and MS. 
Antimicrobial activity
The minimum inhibitory concentration (MIC) values were determined by micro-broth dilution method. The results were compared with activities of standard antibacterial drug streptomycin and antifungal drug miconazole ( Table 1 ). All compounds 6a-f and 7a-f exhibit moderate to potent antibacterial and antifungal activity. It can be seen that compounds exhibit varying degrees of antifungal activity due to the nature of heterocyclic skeleton. Tetrazole derivatives 7a-f are more active compared to 6a-f analogues. Compounds 6f, 7a and 7f are equipotent with miconazole against Candida albicans. Compound 7f shows most potent activity against Candida glabrata. Compounds 6f, 7a, and 7c exhibit more potent activity than 6e, 7b, 7d and 7e against C. glabrata. In addition, compounds 6a, 6b, 6c and 6d show excellent activity against C. glabrata. Compound 7a shows highly potent activity against Candida tropicalis. Compounds 6f, 7b and 7f show more potent activity than 6a, 6e, 7c, 7d and 7e against C. tropicalis.
Biofilm inhibitory activity
Biofilm is surface-adhered bacterial area implanted in an extracellular matrix responsible for the growing resistance in bacteria to antibiotics [22] . Several pathogenic bacteria are found in environments that form biofilm which are structured microbial communities embedded with complex associations with each other. Many serious chronic infections are transmitted to humans via biofilms [23] . Developing new molecules having the ability to inhibit biofilm formation could be one of the solutions for the growing antibiotic resistance. In this regard, the synthesized flavones possessing tetrazole moiety 7a-f were evaluated for anti-biofilm activity against three bacterial strains, namely Staphylococcus aureus NCIM 2178, Bacillus subtilis NCIM 2250, Escherichia coli NCIM 2137 and Pseudomonas aeruginosa NCIM 2036. The results shown in Table 2 reveal that these compounds exhibit good to excellent anti-biofilm activity against all four strains tested. Particularly, compounds 7a, 7e and 7f demonstrate potent efficacy in inhibiting biofilm formation with IC 50 values of 1.3, 1.4, and 0.9 μm, respectively, against P. aeruginosa NCIM 2036.
Conclusions
New tetrazole derivatives were synthesized and evaluated for antibacterial activity, antifungal activity, and bio-film 
Experimental
All reagents were purchased from commercial suppliers and used without purification. The progress of each reaction was monitored by ascending thin-layer chromatography (TLC) using Merck silica gel 60 F 254 plates and visualized using UV light and iodine vapor. Melting points were determined in open capillaries and are uncorrected. Infrared spectra were recorded on a Carry 600 Series FT-IR spectrophotometer using KBr pellets. 1 H NMR (400 MHz) and 13 C NMR (100 MHz) spectra were recorded on a Bruker AVANCE II 400 spectrometer in CDCl 3 or DMSO-d 6 . Mass spectra were recorded on a Waters Q-TOF micro mass instrument equipped with an electro-spray ionization (ESI) source. Elemental analysis was performed on a PerkinElmer EAL-240 elemental analyzer.
General procedure for the synthesis of substituted 2-(2-(4-fluorophenyl)-4-oxo-4H-chromen-3-yloxy)-acetonitriles 6a-f
A mixture of 2-(4-fluorophenyl)-3-hydroxy-4H-chromen-4-one 5a-f (1 mmol), potassium carbonate (2 mmol) and 2-chloroacetonitrile (1 mmol) and DMF was stirred at room temperature for about 3-4 h and analyzed by TLC using petroleum ether/ethyl acetate as an eluent. Then the mixture was quenched with crushed ice and the precipitated solid was collected by filtration and crystallized from ethanol. 2-(4-Fluorophenyl)-8-methyl-4-oxo-4H-chromen-3-yloxy) 
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General procedure for synthesis of 3-((1H-tetrazol-5-yl) methoxy)-2-(4-fluorophenyl)-4H-chromen-4-ones 7a-f
To a mixture of sodium azide (1.5 mmol) and zinc bromide (1.5 mmol) in water (20 mL) was added substituted 2-(2-(4-fluorophenyl)-4-oxo-4H-chromen-3-yloxy)acetonitrile 6a-f (1 mmol). The mixture was then heated under reflux for 4-5 h with vigorous stirring. After completion of the reaction, as evident by TLC analysis using chloroform/ methanol as an eluent, the mixture was quenched with crushed ice and the precipitated solid was collected by filtration and crystallized from ethanol. Tetrazol-5-yl)methoxy)-2-(4-fluorophenyl) Tetrazol-5-yl)methoxy)-6-chloro-2-(4-fluorophenyl) 
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Antimicrobial activity
In vitro antibacterial activity of the synthesized compounds was tested against Gram-positive bacteria S. aureus (NCIM 2178), B. subtilis (NCIM 2250) and Gram-negative bacteria E. coli (NCIM 2137), P. aeruginosa (NCIM 2036). The compounds were also screened for antifungal activity against C. albicans (MTCC 277), C. glabrata (NCIM 3236), C. tropicalis (NCIM 3110). Compounds were diluted in DMSO with 1 μg/mL concentrations for bioassays. Micro-broth dilution method was used to determine MIC values of compounds in 96-well micro-titre plates [24] . Test compounds were serially diluted in growth medium. Plates were incubated at 30°C for fungi and 37°C for bacteria for 24 h. All experiments were carried out in triplicates and mean values are reported.
Biofilm inhibition assay
The flavone-tetrazole conjugates 7a-f were screened in sterile 96 well polystyrene micro-titre plates using the modified bio-film inhibition assay [25] against a panel of pathogenic bacterial strains S. aureus NCIM 2178, B. subtilis NCIM 2250, E. coli NCIM 2137 and P. aeruginosa NCIM 2036, which were cultured overnight in tryptone soy broth (supplemented with 0.5% glucose). The test compounds of predetermined concentrations ranging from 0 to 200 μg/mL were mixed with the bacterial suspensions having an initial inoculums concentration of 5 × 105 cfu mL −1 . Aliquots of 100 μL were distributed in each well and then incubated at 37°C for 24 h under static conditions. Then medium was discarded and washed with phosphate buffered saline to remove the non-adherent bacteria. Micro-titre plate well was stained with 100 μL of 0.1% crystal violet solution followed by 30-min incubation at room temperature. Afterwards the crystal violet solution from the plates was discarded, thoroughly washed with distilled water 3-4 times and air dried at room temperature. The crystal violet stained biofilm was solubilized in 95% ethanol (100 μL) and the absorbance was recorded at 540 nm using a TRIAD multimode reader (Dynex Technologies, USA). All experiments were carried out in triplicates and the values are indicated as mean ± S.D.
